Clearside Biomedical (CLSD) Competitors $3.98 -0.02 (-0.38%) As of 10:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLSD vs. TCRX, SRZN, ORMP, PLRX, ANEB, IPA, ANIX, VIRI, WHWK, and STTKShould you be buying Clearside Biomedical stock or one of its competitors? The main competitors of Clearside Biomedical include TScan Therapeutics (TCRX), Surrozen (SRZN), Oramed Pharmaceuticals (ORMP), Pliant Therapeutics (PLRX), Anebulo Pharmaceuticals (ANEB), ImmunoPrecise Antibodies (IPA), Anixa Biosciences (ANIX), Virios Therapeutics (VIRI), Whitehawk Therapeutics (WHWK), and Shattuck Labs (STTK). These companies are all part of the "pharmaceutical products" industry. Clearside Biomedical vs. Its Competitors TScan Therapeutics Surrozen Oramed Pharmaceuticals Pliant Therapeutics Anebulo Pharmaceuticals ImmunoPrecise Antibodies Anixa Biosciences Virios Therapeutics Whitehawk Therapeutics Shattuck Labs Clearside Biomedical (NASDAQ:CLSD) and TScan Therapeutics (NASDAQ:TCRX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and media sentiment. Do institutionals & insiders believe in CLSD or TCRX? 18.8% of Clearside Biomedical shares are owned by institutional investors. Comparatively, 82.8% of TScan Therapeutics shares are owned by institutional investors. 6.7% of Clearside Biomedical shares are owned by company insiders. Comparatively, 4.4% of TScan Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has higher valuation and earnings, CLSD or TCRX? Clearside Biomedical has higher revenue and earnings than TScan Therapeutics. TScan Therapeutics is trading at a lower price-to-earnings ratio than Clearside Biomedical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearside Biomedical$4.17M5.01-$34.35M-$5.55-0.72TScan Therapeutics$2.82M36.53-$127.50M-$1.09-1.67 Do analysts prefer CLSD or TCRX? Clearside Biomedical currently has a consensus target price of $63.00, indicating a potential upside of 1,480.93%. TScan Therapeutics has a consensus target price of $7.80, indicating a potential upside of 329.75%. Given Clearside Biomedical's higher possible upside, analysts plainly believe Clearside Biomedical is more favorable than TScan Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clearside Biomedical 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17TScan Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CLSD or TCRX more profitable? Clearside Biomedical has a net margin of -665.19% compared to TScan Therapeutics' net margin of -1,964.88%. Clearside Biomedical's return on equity of 0.00% beat TScan Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Clearside Biomedical-665.19% N/A -124.15% TScan Therapeutics -1,964.88%-63.33%-40.19% Which has more volatility and risk, CLSD or TCRX? Clearside Biomedical has a beta of 2.11, meaning that its share price is 111% more volatile than the S&P 500. Comparatively, TScan Therapeutics has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500. Does the media prefer CLSD or TCRX? In the previous week, TScan Therapeutics had 1 more articles in the media than Clearside Biomedical. MarketBeat recorded 3 mentions for TScan Therapeutics and 2 mentions for Clearside Biomedical. TScan Therapeutics' average media sentiment score of 0.67 beat Clearside Biomedical's score of 0.00 indicating that TScan Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clearside Biomedical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TScan Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryClearside Biomedical and TScan Therapeutics tied by winning 8 of the 16 factors compared between the two stocks. Get Clearside Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for CLSD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLSD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLSD vs. The Competition Export to ExcelMetricClearside BiomedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.87M$3.11B$5.70B$10.23BDividend YieldN/A2.36%5.68%4.61%P/E Ratio-0.7220.6376.0426.13Price / Sales5.01387.65516.68165.77Price / CashN/A45.9137.5661.52Price / Book-0.529.7612.676.32Net Income-$34.35M-$52.73M$3.29B$270.94M7 Day Performance2.44%0.63%0.09%-0.10%1 Month Performance-34.05%6.30%4.14%6.37%1 Year Performance-76.28%18.52%65.69%28.45% Clearside Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLSDClearside Biomedical2.0734 of 5 stars$3.99-0.4%$63.00+1,480.9%-76.7%$20.87M$4.17M-0.7230TCRXTScan Therapeutics3.1415 of 5 stars$1.69-4.0%$7.80+361.5%-63.9%$99.88M$2.82M-1.55100Gap UpSRZNSurrozen2.0775 of 5 stars$11.65+0.7%$38.50+230.5%+17.5%$99.12M$10.65M-0.8180ORMPOramed Pharmaceuticals0.3373 of 5 stars$2.32-3.7%N/A+2.1%$98.82M$1.34M-6.6310Positive NewsPLRXPliant Therapeutics4.1144 of 5 stars$1.53-3.8%$8.19+435.1%-87.1%$97.61M$1.58M-0.4590Positive NewsANEBAnebulo Pharmaceuticals1.7577 of 5 stars$2.46+3.8%$5.50+123.6%+17.2%$97.37MN/A-9.464IPAImmunoPrecise Antibodies2.6883 of 5 stars$2.10+8.5%$4.00+90.9%+235.2%$96.68M$17.59M-3.0880Gap UpANIXAnixa Biosciences2.8741 of 5 stars$3.52+20.1%$9.00+155.7%+1.8%$96.61M$210K-10.065Analyst ForecastHigh Trading VolumeVIRIVirios Therapeutics0.3258 of 5 stars$4.89-0.1%$5.00+2.2%+2,548.7%$94.17MN/A-18.115WHWKWhitehawk Therapeutics0.5639 of 5 stars$1.86-6.5%N/AN/A$93.79M$25.98M-31.0021Positive NewsSTTKShattuck Labs4.0109 of 5 stars$1.79-6.8%$4.00+123.5%-36.5%$91.97M$5.72M-1.48100 Related Companies and Tools Related Companies TScan Therapeutics Competitors Surrozen Competitors Oramed Pharmaceuticals Competitors Pliant Therapeutics Competitors Anebulo Pharmaceuticals Competitors ImmunoPrecise Antibodies Competitors Anixa Biosciences Competitors Virios Therapeutics Competitors Whitehawk Therapeutics Competitors Shattuck Labs Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLSD) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearside Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearside Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
